Lucid Capital Management

Lucid Capital Management is a specialized investment bank and financial advisory firm that provides strategic and capital markets solutions to companies in the healthcare, life sciences, and technology sectors. The firm offers a comprehensive suite of services, including M&A advisory, equity research, and capital raising, with a particular focus on middle-market healthcare and biotechnology entities. In March 2026, the firm was notably appointed as the financial advisor to ENDRA Life Sciences to lead its strategic review process. Led by a team of seasoned professionals with deep expertise in healthcare investment banking, Lucid Capital Management is a key player in navigating the financial and strategic landscape for growth-stage life science companies.